Inventor · disambiguated record
David Langdon Yowe
Also filed as: YOWE DAVID · YOWE DAVID LANGDON
9 granted patents·5 pending applications·37 citations·filing 1999–2025
84Inventor score
Files withNOVARTIS AG6MILLENNIUM PHARM INC4GOLDSTEIN JOSHUA1MILLENIUM PHARMACEUTICALS INC1RUE SARAH1
Top patents by PatentIndex Score
14 records- 0188US6410240B1RGS-containing molecules and uses thereofMILLENIUM PHARMACEUTICALS INC·Filed 2000·Granted Jun 25, 2002·23 cites·50 claims
- 0277US2023416407A1Fgf21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0375US8710192B2PCSK9 antagonistsRUE SARAH·Filed 2010·Granted Apr 29, 2014·7 cites·20 claims
- 0475US2025388698A1Fgf21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0569US11692046B2FGF21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2020·Granted Jul 4, 2023·0 cites·13 claims
- 0663US11802152B2Methods of treating FGF21-associated disordersNOVARTIS AG·Filed 2021·Granted Oct 31, 2023·0 cites·7 claims
- 0759US10899844B2FGF21 mimetic antibodies and uses thereofNOVARTIS AG·Filed 2018·Granted Jan 26, 2021·0 cites·10 claims
- 0858US6830914B2RGS-containing molecules and uses thereofMILLENNIUM PHARM INC·Filed 2001·Granted Dec 14, 2004·1 cites·10 claims
- 0954US2005153414A1Novel RGS-containing molecules and uses thereofMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 1049US11236159B2Methods of treating FGF21-associated disordersNOVARTIS AG·Filed 2016·Granted Feb 1, 2022·0 cites·8 claims
- 1143US2010233177A1Molecules and methods for modulating proprotein convertase subtilisin/kexin type 9 (pcsk9)YOWE DAVID LANGDON·Filed 2008·Application pending·0 cites
- 1240US6274362B1RGS-containing molecules and uses thereofMILLENNIUM PHARM INC·Filed 1999·Granted Aug 14, 2001·4 cites·39 claims
- 1333US2013315927A1Pcsk9 antagonistsGOLDSTEIN JOSHUA·Filed 2012·Application pending·0 cites
- 1429US6326481B1Molecules of the AIP-related protein family and uses thereofMILLENNIUM PHARM INC·Filed 1999·Granted Dec 4, 2001·2 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →